Your browser doesn't support javascript.
loading
Sweet's syndrome in the setting of newly initiated risankizumab therapy for pre-existing psoriasis.
Ahmed, Fadwa; Masur, Samuel; Ben Khadra, Shaza; Baig, Muhammad.
Afiliação
  • Ahmed F; Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA fadwa_ahmed@brown.edu.
  • Masur S; Department of Pediatrics and Internal Medicine, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
  • Ben Khadra S; Department of Pathology, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
  • Baig M; Department of Medicine, Miriam Hospital, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
BMJ Case Rep ; 15(2)2022 Feb 08.
Article em En | MEDLINE | ID: mdl-35135798

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Doenças Autoimunes / Síndrome de Sweet Limite: Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Doenças Autoimunes / Síndrome de Sweet Limite: Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article